[Federal Register Volume 61, Number 198 (Thursday, October 10, 1996)]
[Notices]
[Pages 53229-53230]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-25972]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Cancer Institute; Notice of Meeting
    Pursuant to Public Law 92-463, notice is hereby given of a meeting 
of the President's Cancer Panel.
    This meeting will be open to the public as indicated below, with 
attendance by the public limited to space available. Individuals who 
plan to attend and need special assistance, such

[[Page 53230]]

as sign language interpretation or other reasonable accommodations, 
should notify the Contract Person listed below.
    This meeting will be closed in accordance with the provisions set 
forth in section 552b(c)(9), Title 5, U.S.C. for discussion of future 
meetings and preparation of the annual report of the President. These 
discussions could disclose information, the premature disclosure of 
which would be likely to significantly frustrate implementation of 
proposed action the Panel may plan to take.
    Carole Frank, the Committee Management Officer, National Cancer 
Institute, Executive Plaza North, Room 630M, 6130 Executive Blvd., MSC 
7405, Bethesda, MD 20892-7405 (301/496-5708) will provide a summary of 
the meeting and the roster of committee members upon request. Other 
information pertaining to the meetings may be obtained from the contact 
person indicated below.

    Committee Name: President's Cancer Panel.
    Date: October 24-25, 1996.
    Place: Rhode Island Hospital, George Building, George 
Auditorium, 593 Eddy Street, Providence, RI 02903.
    Closed: October 24, 1996--7 p.m. to 9 p.m.
    Agenda: Planning Session to discuss future meetings and 
preparation of the mandatory Annual Report of the Chairman to the 
President.
    Open: October 25, 1996--8:30 a.m. to 5 p.m.
    Agenda: Issues in Translational Research/The Crisis and 
Solutions for Phase I Trials and Associated Issues.
    Contact Person: Dr. Maureen O. Wilson, Executive Secretary, 
National Cancer Institute, Building 31, Room 4A43-2473, 31 Center 
Drive, Bethesda, MD 20892-2473, 301/496-1148.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to proceed with the meeting as 
scheduled in order to address these issues in a timely manner.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: October 3, 1996.
Paula N. Hayes,
Acting Committee Management Officer, NIH.
[FR Doc. 96-25972 Filed 10-9-96; 8:45 am]
BILLING CODE 4140-01-M